Sign in

    QuidelOrtho (QDEL)

    Q1 2026 Earnings Summary

    Reported on Jan 1, 1970 (After Market Close)
    Pre-Earnings Price$25.85Last close (May 7, 2025)
    Post-Earnings Price$28.66Open (May 8, 2025)
    Price Change
    $2.81(+10.87%)
    MetricYoY ChangeReason

    Total Revenue

    -2.7% ( )

    Q1 2026 total revenue fell to $692.8 million from $711.0 million in Q1 2025, a modest decline that suggests mild market contraction and perhaps lower demand in certain segments continuing trends seen in the prior period ( ).

    Operating Income

    Turned positive from a loss of $1,758.0 million to $32.6 million ( )

    Q1 2026 saw a dramatic turnaround in operating income, reversing a steep operating loss in Q1 2025 by reducing the burden of one‑time and non‑cash charges, which indicates improved operational efficiency and stabilization compared to the previous period ( ).

    Net Loss

    Narrowed significantly from $1,706.0 million to $12.7 million ( )

    The net loss contracted sharply in Q1 2026 as improved operating performance and tighter cost management largely offset previous heavy charges, suggesting a strong recovery trajectory relative to Q1 2025 ( ).

    Research analysts covering QuidelOrtho.